Healthcare Companies
-
{
- All
- News
- Videos
-
Epic Games Lays Off More Than 1,000 Employees, CEO Cites Downturn in Fortnite Engagement
- Wednesday March 25, 2026
- Written by Dhruv Raghav, Edited by Ketan Pratap
Epic Games' Chief Executive Officer (CEO) Tim Sweeney announced in a blog post that the Fortnite developer is laying off more than 1,000 employees. The company executive said that the downturn in Fortnite engagement, which began in 2025, was one of the major reasons behind the decision, which will help the company stabilise its finances. However, h...
-
www.gadgets360.com
-
India-US Trade Deal Likely To Offer Tariff Relief On Exported Medicines
- Wednesday February 11, 2026
- Health | Indo-Asian News Service
India's pharmaceutical industry has welcomed the interim trade agreement framework between India and the US, which offers tariff relief on medicines and several other Indian exports.
-
www.ndtv.com
-
OpenAI CEO Sam Altman Teases New ChatGPT Model as Revenue Growth Rebounds: Report
- Tuesday February 10, 2026
- Written by Akash Dutta, Edited by Ketan Pratap
OpenAI might have turned its fortunes this week. As per multiple reports, the company CEO Sam Altman had announced a “code red” in December 2025, asking all employees to focus on improving ChatGPT and related products, while putting everything else on hold. The concentrated effort led to the release of GPT-5.2, adjustable personality traits in ...
-
www.gadgets360.com
-
Oracle Reportedly Considering 30,000 Job Cuts to Fund AI Data Centre Expansion
- Monday February 2, 2026
- Written by Akash Dutta, Edited by Ketan Pratap
Oracle is reportedly considering cutting between 20,000 and 30,000 jobs to fund its artificial intelligence (AI) data centre buildout. As per the report, several US banks have backed out of funding the company’s ambitious plans to build AI data centres after raising questions about the company’s ability to handle such a large-scale project.
-
www.gadgets360.com
-
Indian Drugmakers Recall Medicines In The US Over Manufacturing Issues
- Monday January 26, 2026
- Health | Indo-Asian News Service
Indian drugmakers Sun Pharmaceutical Industries and Cipla have recalled certain products from the US market due to manufacturing-related issues, according to the latest update from the US Food and Drug Administration (USFDA).
-
www.ndtv.com
-
After OpenAI, Now Anthropic Introduces Claude for Healthcare AI Tools
- Monday January 12, 2026
- Written by Akash Dutta, Edited by Ketan Pratap
Anthropic, on Sunday, introduced Claude for Healthcare, a set of custom artificial intelligence (AI) tools aimed at healthcare professionals and consumers seeking information in this area. The offerings include the chatbot powered by a custom Claude Opus 4.5 AI model, third-party integration, as well as agentic skills. The AI startup has also partn...
-
www.gadgets360.com
-
OpenAI Says Over 40 Million Users Have Asked ChatGPT Healthcare Questions: Report
- Tuesday January 6, 2026
- Written by Akash Dutta, Edited by Ketan Pratap
OpenAI’s ChatGPT is reportedly handling a surge in healthcare queries, with over 40 million users asking medical questions, many from rural communities and often outside clinic hours. A common theme is health insurance help, including plan comparisons, claims and billing. It shows AI filling gaps in access to medical information, though accuracy ...
-
www.gadgets360.com
-
Foxconn’s Manufacturing Expansion in India Is Straight Out of Its China Playbook
- Monday December 29, 2025
- Written by Akash Dutta, Edited by Ketan Pratap
Foxconn has scaled its India manufacturing in 2025 with a China-style model that blends vast production campuses with worker ecosystems like housing, healthcare and schools. With a $1.5 billion expansion near Bengaluru and Tamil Nadu and new sites in Greater Noida, Foxconn appears to be diversifying supply chains beyond China.
-
www.gadgets360.com
-
New Study Highlights Drug Pricing And Regulation Issues In India
- Wednesday November 12, 2025
- Health | Written by Rupashi Chhabra
A new government study exposes serious flaws in India's drug pricing and regulation infrastructure. This study reveals how systemic failures impact drug pricing.
-
www.ndtv.com
-
Epic Games Lays Off More Than 1,000 Employees, CEO Cites Downturn in Fortnite Engagement
- Wednesday March 25, 2026
- Written by Dhruv Raghav, Edited by Ketan Pratap
Epic Games' Chief Executive Officer (CEO) Tim Sweeney announced in a blog post that the Fortnite developer is laying off more than 1,000 employees. The company executive said that the downturn in Fortnite engagement, which began in 2025, was one of the major reasons behind the decision, which will help the company stabilise its finances. However, h...
-
www.gadgets360.com
-
India-US Trade Deal Likely To Offer Tariff Relief On Exported Medicines
- Wednesday February 11, 2026
- Health | Indo-Asian News Service
India's pharmaceutical industry has welcomed the interim trade agreement framework between India and the US, which offers tariff relief on medicines and several other Indian exports.
-
www.ndtv.com
-
OpenAI CEO Sam Altman Teases New ChatGPT Model as Revenue Growth Rebounds: Report
- Tuesday February 10, 2026
- Written by Akash Dutta, Edited by Ketan Pratap
OpenAI might have turned its fortunes this week. As per multiple reports, the company CEO Sam Altman had announced a “code red” in December 2025, asking all employees to focus on improving ChatGPT and related products, while putting everything else on hold. The concentrated effort led to the release of GPT-5.2, adjustable personality traits in ...
-
www.gadgets360.com
-
Oracle Reportedly Considering 30,000 Job Cuts to Fund AI Data Centre Expansion
- Monday February 2, 2026
- Written by Akash Dutta, Edited by Ketan Pratap
Oracle is reportedly considering cutting between 20,000 and 30,000 jobs to fund its artificial intelligence (AI) data centre buildout. As per the report, several US banks have backed out of funding the company’s ambitious plans to build AI data centres after raising questions about the company’s ability to handle such a large-scale project.
-
www.gadgets360.com
-
Indian Drugmakers Recall Medicines In The US Over Manufacturing Issues
- Monday January 26, 2026
- Health | Indo-Asian News Service
Indian drugmakers Sun Pharmaceutical Industries and Cipla have recalled certain products from the US market due to manufacturing-related issues, according to the latest update from the US Food and Drug Administration (USFDA).
-
www.ndtv.com
-
After OpenAI, Now Anthropic Introduces Claude for Healthcare AI Tools
- Monday January 12, 2026
- Written by Akash Dutta, Edited by Ketan Pratap
Anthropic, on Sunday, introduced Claude for Healthcare, a set of custom artificial intelligence (AI) tools aimed at healthcare professionals and consumers seeking information in this area. The offerings include the chatbot powered by a custom Claude Opus 4.5 AI model, third-party integration, as well as agentic skills. The AI startup has also partn...
-
www.gadgets360.com
-
OpenAI Says Over 40 Million Users Have Asked ChatGPT Healthcare Questions: Report
- Tuesday January 6, 2026
- Written by Akash Dutta, Edited by Ketan Pratap
OpenAI’s ChatGPT is reportedly handling a surge in healthcare queries, with over 40 million users asking medical questions, many from rural communities and often outside clinic hours. A common theme is health insurance help, including plan comparisons, claims and billing. It shows AI filling gaps in access to medical information, though accuracy ...
-
www.gadgets360.com
-
Foxconn’s Manufacturing Expansion in India Is Straight Out of Its China Playbook
- Monday December 29, 2025
- Written by Akash Dutta, Edited by Ketan Pratap
Foxconn has scaled its India manufacturing in 2025 with a China-style model that blends vast production campuses with worker ecosystems like housing, healthcare and schools. With a $1.5 billion expansion near Bengaluru and Tamil Nadu and new sites in Greater Noida, Foxconn appears to be diversifying supply chains beyond China.
-
www.gadgets360.com
-
New Study Highlights Drug Pricing And Regulation Issues In India
- Wednesday November 12, 2025
- Health | Written by Rupashi Chhabra
A new government study exposes serious flaws in India's drug pricing and regulation infrastructure. This study reveals how systemic failures impact drug pricing.
-
www.ndtv.com